von Tobias Borgers | Jan 19, 2024 | Bayer
Sun Pharmaceutical Industries Limited and Bayer on Thursday announced that both companies have signed an agreement to market and distribute a second brand of Finerenone in India. According to the company’s press statement, Finerenone, a patented medicine is indicated...
von Tobias Borgers | Jan 10, 2024 | Markt
The need for innovation in drug-making Introduction to PAT in pharmaceutical manufacturing Real-time monitoring and control Reducing variability and waste References Further reading Technological innovations throughout the past several decades have transformed the...
von Tobias Borgers | Jan 10, 2024 | Boehringer
INGELHEIM, Germany and SOUTH SAN FRANCISCO, Calif., Jan. 4, 2024 /PRNewswire/ — Boehringer Ingelheim and 3T Biosciences („3T“) today announced they have entered into a new strategic collaboration and licensing agreement focused on discovering and...
von Tobias Borgers | Jan 10, 2024 | Glaxo
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway AIO-001 could redefine the standard-of-care with dosing every six months AIO-001 has potential to expand GSK’s...
von Tobias Borgers | Jan 3, 2024 | Markt
Digital technologies will help safeguard drug and vaccine supplies during health emergencies according to the European Medicines Agency (EMA), which says efforts to foster manufacturing innovation are on track. The regulator discussed digitization in a progress report...
